These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20397934)

  • 1. Oseltamivir dosing in children undergoing hemodialysis.
    Schreuder MF; van der Flier M; Knops NB; Koster-Kamphuis L; Brüggemann RJ
    Clin Infect Dis; 2010 May; 50(10):1427-8. PubMed ID: 20397934
    [No Abstract]   [Full Text] [Related]  

  • 2. Oseltamivir and its active metabolite cross the placenta at significant levels.
    Meijer WJ; Bruinse HW; van den Broek MP; Kromdijk W; Wensing AM
    Clin Infect Dis; 2012 Jun; 54(11):1676-7. PubMed ID: 22460968
    [No Abstract]   [Full Text] [Related]  

  • 3. First isolation of a oseltamivir-resistant influenza A (H1N1) strain in Argentina.
    Cané A; Casanueva E; Iolster T; Sticco N; Richards L; Sosa P; Pontoriero A; Avaro M; Zcech A; Carabajal E; Campos A; Baumeister E; Diez MA; Rojas M; Rivarola MR
    Pediatr Infect Dis J; 2010 Apr; 29(4):384. PubMed ID: 20351531
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season.
    Kawakami C; Obuchi M; Saikusa M; Noguchi Y; Ujike M; Odagiri T; Iwata M; Toyozawa T; Tashiro M
    Jpn J Infect Dis; 2009 Jan; 62(1):83-6. PubMed ID: 19168972
    [No Abstract]   [Full Text] [Related]  

  • 5. 2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease.
    Launes C; García-García JJ; Jordán I; Martínez-Planas A; Selva L; Muñoz-Almagro C
    Pediatr Infect Dis J; 2011 Jul; 30(7):622-5. PubMed ID: 21200359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign clinical course in H1N1 2009 influenza infection in young oseltamivir-treated immunocompromised patients with kidney disease in Singapore.
    Ng KH; Quak ZX; Chan YH; Suhaila M; Lau PY; Tambyah PA; Tang JW; Yap HK
    Pediatr Infect Dis J; 2013 Mar; 32(3):298-300. PubMed ID: 23249911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
    Rodríguez A; Díaz E; Martín-Loeches I; Sandiumenge A; Canadell L; Díaz JJ; Figueira JC; Marques A; Alvarez-Lerma F; Vallés J; Baladín B; García-López F; Suberviola B; Zaragoza R; Trefler S; Bonastre J; Blanquer J; Rello J;
    J Antimicrob Chemother; 2011 May; 66(5):1140-9. PubMed ID: 21385717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
    Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A caution about giving Tamiflu to children.
    Child Health Alert; 2009 Nov; 27():4-5. PubMed ID: 20050174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?].
    Rosenborg S
    Lakartidningen; 2010 Jan 20-26; 107(3):116-7. PubMed ID: 20225688
    [No Abstract]   [Full Text] [Related]  

  • 11. Oseltamivir dosing for influenza infection in premature neonates.
    Acosta EP; Jester P; Gal P; Wimmer J; Wade J; Whitley RJ; Kimberlin DW;
    J Infect Dis; 2010 Aug; 202(4):563-6. PubMed ID: 20594104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. EUA issued for treating novel 2009 H1N1 flu.
    AIDS Alert; 2009 Jun; 24(6):69-70. PubMed ID: 19544608
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure.
    Karie S; Launay-Vacher V; Janus N; Izzedine H; Deray G
    Nephrol Dial Transplant; 2006 Dec; 21(12):3606-8. PubMed ID: 16799172
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Eyler RF; Heung M; Pleva M; Sowinski KM; Park PK; Napolitano LM; Mueller BA
    Pharmacotherapy; 2012 Dec; 32(12):1061-9. PubMed ID: 23208833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.
    Kumar A
    J Antimicrob Chemother; 2011 May; 66(5):959-63. PubMed ID: 21406435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping alert to changes during the pandemic.
    Thompson C; Rolls S
    Nurs N Z; 2009 Aug; 15(7):30. PubMed ID: 19785327
    [No Abstract]   [Full Text] [Related]  

  • 19. Pericardial effusion complicating novel influenza A (H1N1) infection in an infant.
    Koranyi K; Yontz D; Rohrer Z; Leber A; Ramilo O
    Pediatr Infect Dis J; 2010 Aug; 29(8):782-3. PubMed ID: 20661108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.